БЕЗОПАСНОСТЬ ИНГИБИТОРОВ АНГИОТЕНЗИНПРЕВРАЩАЮЩЕГО ФЕРМЕНТА В РАННИЕ СРОКИ БЕРЕМЕННОСТИ
We systematically reviewed the studies evaluating the risk of major malformations. Studies results suggest that first trimester exposure to angiotensin converting enzyme inhibitors is not associated with an elevated risk of major malformations compared with other antihypertensives.
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
SINAPS LLC,
2015-02-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | We systematically reviewed the studies evaluating the risk of major malformations. Studies results suggest that first trimester exposure to angiotensin converting enzyme inhibitors is not associated with an elevated risk of major malformations compared with other antihypertensives. |
|---|---|
| Item Description: | 2226-6704 2411-6564 10.20514/2226-6704-2015-0-1-58-59 |